高级检索
当前位置: 首页 > 详情页

Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai 200032, Peoples R China [2]Heidelberg Univ, Med Fac Mannheim, Dept Med 2, Div Hepatol, Heidelberg, Germany [3]Johann Wolfgang Goethe Univ Klinikum, Med Dept 1, Frankfurt, Germany [4]Univ Bern, Inselspital, Univ Clin Visceral Surg & Med, Hepatol, Bern, Switzerland [5]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China [6]Caritas Krankenhaus Bad Mergentheim, Med Dept 2, D-97980 Bad Mergentheim, Germany
出处:
ISSN:

关键词: Contrast-enhanced ultrasound (CEUS) Diagnosis Differentiate Mixed hepatocellular cholangiocarcinoma (HCC-CCA)

摘要:
Background: Mixed hepatocellular cholangiocarcinoma is a rare form of primary liver cancer. Aims: The aim of this study is to report the results of the use of contrast enhanced ultrasound in a series of patients with confirmed mixed hepatocellular cholangiocarcinoma and to provide an updated literature review. Methods: Between January 2012 and October 2016, 25 Asian patients with confirmed mixed hepatocellular cholangiocarcinoma were included in this bicentric retrospective analysis. Clinical data as well recorded images of a standardized conventional B-mode ultrasound and contrast-enhanced ultrasound examination were interpreted by two blinded, independent, experienced radiologists in consensus. Results: All mixed hepatocellular cholangiocarcinoma lesions were heteroechoic on B-mode ultrasound, with ill-defined margins and irregular shapes. Arterial phase hyperenhancement was present in all 25 patients. Late-phase washout and hypoenhancement was present in 24/25 (96%) patients. However, rim enhancement and early wash-out (which are common in cholangiocellular carcinoma) were found in over 60% of the cases. Conclusion: Contrast-enhanced ultrasound demonstrated findings not typical for HCC in a large proportion of patients with confirmed mixed hepatocellular cholangiocarcinoma. Therefore, histological confirmation is crucial, especially in lesions with atypical findings. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 胃肠肝病学
最新[2025]版:
大类 | 2 区 医学
小类 | 3 区 胃肠肝病学
JCR分区:
出版当年[2016]版:
Q2 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai 200032, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:589 今日访问量:0 总访问量:441 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)